UK hospital to trial blood plasma Covid-19 treatment
Using antibodies from recovered patients has been used to treat Ebola and Sars
A hospital in Wales is trialling a potential new treatment for coronavirus that could offer patients a “glimmer of hope”, experts say.
The University Hospital of Wales (UHW) in Cardiff hopes to offer the plasma therapy as part of a study within a month.
Blood would be taken from people who have recovered from coronavirus and the plasma in that blood is then given to ill patients. It is thought that antibodies in the blood of previously infected patients could help others to fight the infection.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Dr Stuart Walker, medical director at Cardiff and Vale University Health Board, said: “At the moment there are no other treatments per se for the viral infection itself, so this does give us a glimmer of hope.
“When you have an illness like this you produce a response in the form of antibodies in the bloodstream. Those antibodies can potentially negate the effects of the virus in people who are suffering from it in a more severe way.”
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
The BBC reports that Public Health Wales will identify and write to potential donors, with the plasma collected and processed by the Welsh Blood Service. “Donors will need to have tested positive for Covid-19 and now be fully recovered,” the report adds.
The broadcaster has also been told that other hospitals across the UK are also looking to trial the plasma treatment, with further announcements imminent.
According to Sky News, doctors have expressed frustration at the government for failing to approve trials for plasma therapy faster.
Trials are already under way in other countries including China, France, Germany and the US, the broadcaster adds.
Earlier this week, Dr Colin Hamilton-Davies, who heads the acute cardiac critical care unit at Bart’s Hospital in London, told Sky News: “We have a national health service and blood service that is the envy of the world, we have a very substantially-sized department of blood transfusion, and for people harvesting blood plasma, we could step it up within a week.
“We could be administering it, not just to one or two people, but hundreds of patients.”
Plasma treatment has been used with some success for Ebola and Sars, according to the World Health Organization. However, there is no known effective treatment for Covid-19.
Dr Muhammad Munir, a molecular virologist at Lancaster University, added: “Plasma treatment is an interim solution and should be done at all costs because what we’re looking into is a vaccine for next year. The plasma is something we can offer and it is in our hands.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
This is what you should know about State Department travel advisories and warnings
In Depth Stay safe on your international adventures
By Catherine Garcia, The Week US Published
-
'All Tyson-Paul promised was spectacle and, in the end, that's all we got'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
By Julia O'Driscoll, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published